Wikipedia:
Acetyldigoxin
 |
|
|
Acetyldigoxin
|
|
| Systematic (IUPAC) name | |
| [6-[6-[ [6-[ [12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxyoxan-2-yl]methoxy]-4-hydroxy-2-methyloxan-3-yl]oxy-3-hydroxy-2-methyloxan-4-yl] acetate | |
| Identifiers | |
| CAS number | |
| ATC code | C01 |
| PubChem | |
| Chemical data | |
| Formula | C43H66O15 |
| Mol. mass | 822.975 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Acetyldigoxin is a cardiac glycoside. It is an acetyl derivative of digoxin.
| Cardiac glycosides (C01A) | |
|---|---|
| Digitalis glycosides | Acetyldigitoxin - Acetyldigoxin - Digitalis leaves - Digitoxin - Digoxin - Lanatoside C - Deslanoside - Metildigoxin - Gitoformate |
| Scilla glycosides | Proscillaridin |
| Strophantus glycosides | G-strophanthin - Cymarin |
| Other cardiac glycosides | Peruvoside |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
